Cargando…
Targeting Immune Signaling Checkpoints in Acute Myeloid Leukemia
The modest successes of targeted therapies along with the curative effects of allogeneic hematopoietic stem cell transplantation (alloHSCT) in acute myeloid leukemia (AML) stimulate the development of new immunotherapies. One of the promising methods of immunotherapy is the activation of immune resp...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6406869/ https://www.ncbi.nlm.nih.gov/pubmed/30759726 http://dx.doi.org/10.3390/jcm8020236 |